Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1B | P47901 | 7/20 | 0.47 |
| ▸ | PLG | P00747 | 1/20 | 0.44 |
| ▸ | AVPR1A | P37288 | 9/20 | 0.44 |
| ▸ | BMP1 | P13497 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9329697 | 0.88 | AVPR1B (0.52) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL7898282 | 0.87 | AVPR1B (0.54) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL1509780 | 0.87 | AVPR1B (0.54) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL30007346 | 0.87 | AVPR1B (0.54) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL1509781 | 0.87 | AVPR1B (0.54) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL2873083 | 0.86 | AVPR1B (0.48) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL29816989 | 0.86 | AVPR1B (0.48) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL7368157 | 0.86 | AVPR1B (0.47) | AVPR1BPLGAVPR1ABMP1F2 | |
| SCHEMBL1738663 | 0.83 | AVPR1B (0.52) | AVPR1BPLGAVPR1ABMP1 | |
| SCHEMBL7171393 | 0.78 | AVPR1B (0.46) | AVPR1BPLGAVPR1ABMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1858538-B1 | MUCIN HYPERSECRETION INHIBITORS BASED ON THE STRUCTURE OF MANS AND METHODS OF USE | BIOMARCK PHARMACEUTICALS LTD (US) | 2019-03-27 | — | — | EP | disclosed |
| US-9598463-B2 | Mucin hypersecretion inhibitors and methods of use | BIOMARCK PHARMACEUTICALS, LTD. (US) | 2017-03-21 | — | — | US | disclosed |
| US-20150274778-A1 | MUCIN HYPERSECRETION INHIBITORS AND METHODS OF USE | BIOMARCK PHARMACEUTICALS, LTD. | 2015-10-01 | — | — | US | disclosed |
| US-8907056-B2 | Mucin hypersecretion inhibitors and methods of use | BIOMARCK PHARMACEUTICALS, LTD. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20130338085-A1 | MUCIN HYPERSECRETION INHIBITORS AND METHODS OF USE | BIOMARCK PHARMACEUTICALS, LTD. | 2013-12-19 | — | — | US | disclosed |
| US-8492518-B2 | Mucin hypersecretion inhibitors and methods of use | BIOMARCK PHARMACEUTICALS LTD. (US) | 2013-07-23 | — | — | US | disclosed |
| US-8293870-B2 | Mucin hypersecretion inhibitors and methods of use | BIOMARCK PHARMACEUTICALS LTD (US) | 2012-10-23 | — | — | US | disclosed |
| US-20100197607-A1 | MUCIN HYPERSECRETION INHIBITORS AND METHODS OF USE | WILLIAMS, MASON L. | 2010-08-05 | — | — | US | disclosed |
| US-20090275520-A1 | MUCIN HYPERSECRETION INHIBITORS AND METHODS OF USE | WILLIAMS, MASON L. | 2009-11-05 | — | — | US | disclosed |
| US-7524926-B2 | Mucin hypersecretion inhibitors and methods of use | BIOMARCK PHARMACEUTICALS, LTD. (US) | 2009-04-28 | — | — | US | disclosed |
| US-20060205664-A1 | Mucin hypersecretion inhibitors and methods of use | WILLIAMS, MASON L. | 2006-09-14 | — | — | US | disclosed |
| WO-2002072068-A2 | LIPIDS, LIPID COMPOSITIONS, LIPOSOMES, AND LIPOPLEXES | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2002-09-19 | — | — | WO | disclosed |